CD91:XETRA:XETRA-Amundi Index Solutions - Amundi NYSE Arca Gold BUGS UCITS ETF USD Distributing (EUR)

ETF | Others |

Last Closing

USD 24.43

Change

+0.30 (+1.22)%

Market Cap

USD 0.28B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.50 (+1.00%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.11 (+0.66%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.16 (+0.62%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.20 (+0.72%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.03 (+0.11%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

+1.76 (+1.13%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

+0.32 (+0.74%)

USD 105.55B
8R80:XETRA Amundi Index Solutions - Amund..

+0.72 (+0.51%)

USD 105.05B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.32 (+0.64%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-3.88 (-0.75%)

USD 80.38B

ETFs Containing CD91:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.34% 89% A- 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.34% 89% A- 86% B+
Trailing 12 Months  
Capital Gain -1.49% 14% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.49% 13% F 21% F
Trailing 5 Years  
Capital Gain 86.18% 90% A- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 86.18% 90% A- 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 5.56% 57% F 55% F
Dividend Return 5.80% 57% F 54% F
Total Return N/A 8% B- 5% F
Risk Return Profile  
Volatility (Standard Deviation) 24.26% 16% F 27% F
Risk Adjusted Return 23.89% 44% F 45% F
Market Capitalization 0.28B 55% F 49% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.